CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2017	Jun. 30, 2016
Cash flows from operating activities:
Net loss	$ (2,845)	$ (127)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	78	84
Amortization	2
Interest expense - debt discount	587
Accretion of original issue discount on notes receivable - related party	(19)
Interest expense on extinguishment of demand notes to common stock	13
Stock-based compensation	752	87
Changes in operating assets and liabilities:
Accounts receivable	651	4
Inventories	216	256
Prepaid expenses and other current assets	72	53
Other assets	(82)
Accounts payable and accrued expenses	(91)	(25)
Accounts payable, related parties	100
Other current liabilities	(307)	(198)
Net cash (used in) provided by operating activities	(873)	134
Cash flows from investing activities:
Purchase of property and equipment	(21)	(74)
Investments - related party	(1,527)
Related party investment in real property	(300)
Investments - others	(95)
Loan to third party	(489)
Net cash used in investing activities	(2,432)	(74)
Cash flows from financing activities:
Gross proceeds from sales of common stock and warrants	300
Proceeds from issuance of preferred stock	1,540
Financing cost in connection with sales of equity securities	(275)
Proceeds from convertible notes payable	354
Proceeds from notes payable - related party	350
Proceeds from notes payable	710
Payments on revolving credit facility, net	(268)
Net cash provided by financing activities	2,711
Effect of exchange rate on cash and cash equivalents	41	(89)
Net decrease in cash and cash equivalents	(553)	(29)
Cash and cash equivalents at beginning of period	996	1,241
Cash and cash equivalents at end of period	443	1,212
Supplemental disclosures of cash flow information:
Cash paid during the period for interest	32
Non-cash investing and financing activities:
Cancellation of notes payable - related party into shares of common stock	100
Cancellation of notes payable into shares of common stock	$ 625
Cancellation of note payable - related party into series B convertible preferred stock	500
In connection with the Company's acquisition of Microphase Corporation, equity instruments were issued and liabilities assumed during 2017 as follows:
Fair value of assets acquired	$ 7,893
Equity instruments issued	(1,451)
Minority interest	(945)
Liabilities assumed	$ 5,497